These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8379434)

  • 21. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
    Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
    Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel strategy for immunotherapy using antibody-coupled carriers to focus cytotoxic T helper cells.
    Ochi A; Worton KS; Woods G; Gravelle M; Kitagami K
    Eur J Immunol; 1987 Nov; 17(11):1645-8. PubMed ID: 2960548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
    Savelyeva N; King CA; Vitetta ES; Stevenson FK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of anti-idiotypic antibodies to a myeloma protein linked covalently to muramyl dipeptide.
    Eggers AE; Michl J
    J Immunol Methods; 1990 Oct; 133(1):71-5. PubMed ID: 2212693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.
    Betting DJ; Kafi K; Abdollahi-Fard A; Hurvitz SA; Timmerman JM
    J Immunol; 2008 Sep; 181(6):4131-40. PubMed ID: 18768870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiotypic responses induced by tumor: an autocrine network.
    Köhler H; Raychaudhuri S; Chen JJ; Saeki Y
    Int Rev Immunol; 1989; 4(4):311-20. PubMed ID: 2535274
    [No Abstract]   [Full Text] [Related]  

  • 29. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
    Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
    Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DCs in lymphoma--biology and therapeutic aspects.
    Schultze JL; Fiore F; von Bergwelt-Baildon M
    Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
    [No Abstract]   [Full Text] [Related]  

  • 31. Internal complementarities in the immune system: regulation of the expression of helper T-cell idiotypes.
    Martinez C; Pereira P; Bernabé R; Bandeira A; Larsson EL; Cazenave PA; Coutinho A
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4520-3. PubMed ID: 6235521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    Int Rev Immunol; 1989; 4(4):251-70. PubMed ID: 2519929
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy.
    Schultz ES; Schuler-Thurner B; Stroobant V; Jenne L; Berger TG; Thielemanns K; van der Bruggen P; Schuler G
    J Immunol; 2004 Jan; 172(2):1304-10. PubMed ID: 14707109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.
    Singh A; Qin H; Fernandez I; Wei J; Lin J; Kwak LW; Roy K
    J Control Release; 2011 Oct; 155(2):184-92. PubMed ID: 21708196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of xenogenized vaccine cells in vivo.
    Graf N; Adam C; Mocikat R
    Int J Cancer; 2003 Jun; 105(2):217-20. PubMed ID: 12673682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells.
    Lou Q; Conway TF; Egilmez NK; Loyall JL; Bernstein SH; Kelleher RJ; Bankert RB
    Clin Immunol; 2006 Jan; 118(1):66-76. PubMed ID: 16185929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK.
    Rees RC; Pawelec G; Müller L; Robins A
    Cancer Immunol Immunother; 2002 Mar; 51(1):58-61. PubMed ID: 11845261
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
    Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
    J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.